KR880005136A - 퀴놀린계 화합물, 그의 제조방법 및 그 화합물을 약효성분으로 함유하는 항암제 - Google Patents

퀴놀린계 화합물, 그의 제조방법 및 그 화합물을 약효성분으로 함유하는 항암제 Download PDF

Info

Publication number
KR880005136A
KR880005136A KR870011530A KR870011530A KR880005136A KR 880005136 A KR880005136 A KR 880005136A KR 870011530 A KR870011530 A KR 870011530A KR 870011530 A KR870011530 A KR 870011530A KR 880005136 A KR880005136 A KR 880005136A
Authority
KR
South Korea
Prior art keywords
compound
anticancer agent
general formula
preparation
active ingredient
Prior art date
Application number
KR870011530A
Other languages
English (en)
Other versions
KR900003499B1 (ko
Inventor
마사도시 야마또
Original Assignee
곤도 야스노리
메꾸또 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 곤도 야스노리, 메꾸또 가부시끼가이샤 filed Critical 곤도 야스노리
Publication of KR880005136A publication Critical patent/KR880005136A/ko
Application granted granted Critical
Publication of KR900003499B1 publication Critical patent/KR900003499B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

퀴놀린계 화합물, 그의 제조방법 및 그 화합물을 약효성분으로 함유하는 항암제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 다음 일반식(1)로 표시되는 퀴놀린계 화합물.
    여기서 X는 CH2, O 또는 S이다.
  2. 다음 일반식(2)로 표시되는 화합물과 N-(4-아미노-3-메톡시페닐)메탄술폰아미드를 반응시키는 단계로 이루어진 것을 특징으로 하는 다음 일반식(1)로 표시되는 퀴놀린계 화합물의 제조방법.
    상기 식들에서 X는 CH2, O 또는 S이며, Ha1은 할로겐원소를 나타낸다.
  3. 제 2 항에 있어서, 상기 일반식(2) 중의 Ha1은 염소인 것을 특징으로 하는 제조방법.
  4. 다음 일반식(1)로 표시되는 약효성분을 포함하는 것을 특징으로 하는 항암제.
    여기서 X는 CH2, O 또는 S이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870011530A 1986-10-17 1987-10-17 퀴놀린계 화합물, 그의 제조방법 및 그 화합물을 약효성분으로 함유하는 항암제 KR900003499B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP61246776A JPS63101369A (ja) 1986-10-17 1986-10-17 インデノキノリン系化合物、その製造法及びその化合物を有効成分とする抗癌剤
JP61-246776 1986-10-17
JP246776 1986-10-17

Publications (2)

Publication Number Publication Date
KR880005136A true KR880005136A (ko) 1988-06-28
KR900003499B1 KR900003499B1 (ko) 1990-05-21

Family

ID=17153489

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870011530A KR900003499B1 (ko) 1986-10-17 1987-10-17 퀴놀린계 화합물, 그의 제조방법 및 그 화합물을 약효성분으로 함유하는 항암제

Country Status (12)

Country Link
US (1) US4826850A (ko)
EP (1) EP0264124B1 (ko)
JP (1) JPS63101369A (ko)
KR (1) KR900003499B1 (ko)
CN (1) CN1009826B (ko)
AT (1) ATE73447T1 (ko)
AU (1) AU598878B2 (ko)
DE (1) DE3777319D1 (ko)
DK (1) DK543987A (ko)
ES (1) ES2033279T3 (ko)
GR (1) GR3004353T3 (ko)
NZ (1) NZ222185A (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01228965A (ja) * 1988-03-10 1989-09-12 Mect Corp 縮合キノリン系化合物及び縮合アクリジン系化合物、それらの製造法ならびにそれらの化合物を有効成分とする抗癌剤
JPH0692410B2 (ja) * 1988-08-30 1994-11-16 キッセイ薬品工業株式会社 新規なベンゾフロキノリン誘導体
US5217961A (en) * 1988-12-27 1993-06-08 Mect Corporation Condensed quinoline system N-glycosides
JPH02256667A (ja) * 1988-12-27 1990-10-17 Masatoshi Yamato 縮合キノリン系化合物およびその製造方法
AU640135B2 (en) * 1990-03-20 1993-08-19 Wellcome Foundation Limited, The Hetero polycyclic biocidal compounds and their use in medicine
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
US5681958A (en) * 1995-06-07 1997-10-28 Shaman Pharmaceuticals, Inc. Cryptolepine analogs with hypoglycemic activity
JP3141148B2 (ja) * 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
US5741926A (en) * 1997-02-12 1998-04-21 Shaman Pharmaceuticals, Inc. Aniline derivatives having antihyperglycemic activity
CN105622508B (zh) * 2015-12-22 2018-08-21 广西师范大学 一种新的[1,2,b]茚并喹啉类衍生物及其制备方法和在抗肿瘤药物中的应用
CN107325110B (zh) * 2017-07-21 2019-06-11 太原理工大学 一种四元杂环苯并噻吩并喹啉化合物及其合成方法
CN110256451B (zh) * 2019-07-15 2021-09-03 河南省科学院化学研究所有限公司 一种苯并呋喃并[2,3-b]喹啉衍生物的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200715A (en) * 1982-05-24 1986-06-11 New Zealand Dev Finance Acridine derivatives and pharmaceutical compositions containing such

Also Published As

Publication number Publication date
AU598878B2 (en) 1990-07-05
CN87106996A (zh) 1988-06-15
DE3777319D1 (de) 1992-04-16
AU7987587A (en) 1988-04-21
EP0264124A1 (en) 1988-04-20
EP0264124B1 (en) 1992-03-11
KR900003499B1 (ko) 1990-05-21
NZ222185A (en) 1990-07-26
US4826850A (en) 1989-05-02
GR3004353T3 (ko) 1993-03-31
DK543987D0 (da) 1987-10-16
JPS63101369A (ja) 1988-05-06
ES2033279T3 (es) 1993-03-16
ATE73447T1 (de) 1992-03-15
CN1009826B (zh) 1990-10-03
DK543987A (da) 1988-04-18

Similar Documents

Publication Publication Date Title
KR880005136A (ko) 퀴놀린계 화합물, 그의 제조방법 및 그 화합물을 약효성분으로 함유하는 항암제
DK77090D0 (da) Immunmodulerende azaspiraner
KR860001110A (ko) 항균제 ⅱ의 제법
FR2647787B1 (fr) Nouveaux thiazolylalkoxyacrylates, leur procede de preparation, leur application comme fongicides et leurs intermediaires de preparation
DE3772015D1 (de) Chinolinverbindung.
KR910016695A (ko) 4-(아미노메틸) 피페리딘 유도체, 그의 제조방법 및 치료에의 이용
YU144790A (sh) 5-alkil-1,3-4-tiadiazoli, postupak za njihovu izradu i primena kao sredstvo za suzbijanje štetočina
NO894349D0 (no) Tienopyridin-type mevalonolaktoner.
SE8705150D0 (sv) Novel antiarrhythmic agents
FR2401147A1 (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6, utiles comme intermediaires chimiques dans la synthese de medicaments
KR890014536A (ko) 축합 퀴놀린계 화합물, 축합 아크리딘계 화합물 및 그의 제조방법과 그것을 함유하는 항암제 조성물
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물
FR2361883A2 (fr) Amides de la pyrrolidino ethyl amine utilisables en therapeutique pulmonaire
KR880001628A (ko) 비사이클릭 방향족 설포닐 클로라이드의 합성
ATE59640T1 (de) Fungizide.
KR870001172A (ko) 신규한 벤즈아미드의 제법
KR920016441A (ko) 글리세르알데하이드-3-펜타나이드 및 이의 제조방법
FR2446636A1 (fr) Nouvelles compositions pharmaceutiques a base d'une benzo(c) (1,6)naphtyridine
FI873251A0 (fi) 2,6-bis(klormetyloxi-karbonyloximetyl) pyridin och foerfarande foer dess framstaellning.
KR860007876A (ko) 제초제 조성물
KR870010013A (ko) 디할로겐치환 티오시아노피리미딘 유도체, 그의 제조방법 및 농원예용 살균제
TH2356A (th) อนุพันธ์ของไนโตรเมทธิลลีนเตตราไฮโดรไพริมิดีนกระบวนการสำหรับผลิตสารเหล่านี้ และสารกำจัดแมลงกำจัดไรและกำจัดไส้เดือนฝอย
TH2356EX (th) อนุพันธ์ของไนโตรเมทธิลลีนเตตราไฮโดรไพริมิดีนกระบวนการสำหรับผลิตสารเหล่านี้ และสารกำจัดแมลงกำจัดไรและกำจัดไส้เดือนฝอย
ES540693A0 (es) Un procedimiento de preparar sales quinato de alfa-2-piperi-dinil-2,8-bis(trifluorometil)-4-quinolino-metanol
ATE67188T1 (de) Verfahren zur stabilisierung von procaterol.

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930422

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee